As part of the search for new bioactive plants from the Colombian Caribbean, the dichloromethane fraction of the calyces of Physalis angulata L. (PADF) was selected for its anti-inflammatory activity. In this work, we investigated the immunomodulatory effect of PADF in activated macrophages and during dextran sulfate sodium (DSS)-induced colitis. PADF displayed a low content of withanolides or phenolic compounds, and a higher content of sucrose esters, representative anti-inflammatory metabolites of the Physalis genus. The PADF fraction at 12.5 µg/mL prevented the induction of interleukin (IL)-1β, tumor necrosis factor (TNF-α), IL-6, IL-12, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS), while increased the levels of arginase (ARG1), IL-10, and mannose receptor C (MRC1). The polarization towards an anti-inflammatory profile was also observed in resting macrophages, without promoting the typical gene profile induced by IL-4, suggesting that PADF promotes a shift to a regulatory status rather than to an alternative one. In vivo, the administration of PADF to mice with chronic DSS-colitis reduced disease signs (i.e., body weight loss and colon shortening), and improved the histology score by diminishing the levels of pro-inflammatory cytokines and increasing the production of IL-10. Overall, results suggest that the regulatory effect on PADF towards macrophages might contribute to the therapeutic activity observed in the murine model of inflammatory bowel disease.
Introduction
The discovery of novel bioactive compounds from medicinal plants and animals continues to be an interesting/attractive strategy for the development of new drugs with a unique chemical and pharmacological profile; in fact, a new golden era for natural product research is anticipated from the recent technological advances and the current attention to naturally-derived drugs motivated by the 2015 Nobel Prize in Physiology or Medicine awarded to William C. Campbell, Satoshi Omura, and Youyou Tu for the discovery of avermectins and artemisinin, respectively [1] .
Certainly, herbal medicines and metabolites have a high potential to treat a wide spectrum of diseases, and are used not only in developing countries, where up to 80% of the population still depends on traditional medicine and medicinal herbs for primary health care, but also in developed countries, where the influence of natural products in the pharmaceutical industry is remarkable [2, 3] . Colombia, having one of the largest and complex biodiversity, has enormous potential to generate scientific knowledge to establish an innovative, sustainable, and profitable local industry for natural health products. The Physalis genus (Solanaceae), which includes 90 species native to America, constitutes IL-12, cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), arginase (ARG1), IL-10, transforming growth factor, beta 1 (TGF-β1), and mannose receptor C (MRC1) using a LightCycler 96 and the Fast Start Essential DNA Green Master (Roche, Mannheim, Germany). Specific primers (Eurofins Genomics, Huntsville, USA) sequences are listed in Table 1 . Gene expression was normalized to β-actin, using duplicate cycle threshold (CT) values analyzed by the comparative CT (∆∆CT) method. 
Animals
Four-week-old female CD-1(ICR) mice were obtained from the Instituto Nacional de Salud (Bogotá, Colombia). Animals were housed in filtered-capped polycarbonate cages and kept in a controlled environment (22 ± 3 • C, 65-75% humidity, under a 12 h light/darkness cycle) with access to food and water ad libitum. All the experiments were designed and conducted in accordance with local and international regulations (EU Directive 2010/63/EU) and approved by the Committee of Ethics in Research of the University of Cartagena (Project Approval No 81 from 13 August 2015).
DSS-Induced Colitis Model
Animals were randomized into control (vehicle), colitis-control (DSS group), and treatment groups (n = 6-17). Colitis was induced with 4% (w/v) DSS in drinking water during two seven-day cycles, separated by ten days of regular water. Two doses of PADF (5 and 10 mg/Kg) were administered intraperitoneally (i.p.) during seven days after DSS withdrawal, while the control group was treated with saline. Body weight and disease activity index (DAI) were monitored exhaustively [12] . Macroscopic parameters, such as colon length and weight/length ratio were also measured after mice sacrifice.
Histologic Analysis
Colonic tissue samples were preserved in buffered formalin and embedded in paraffin, 5 µm sections were cut and stained with H&E. Damage to the epithelial structure and cell infiltration in the colonic tissue were qualified using a 0 to 4 score (0: none, 1: mild, 2: moderate, 3: high and 4: very high) by a blind pathologist using light microscopy (Axio Lab A1, Zeiss, Oberkochen, Germany).
Myeloperoxidase (MPO) Activity Assessment
MPO activity was measured according to the method described by Bradley et al. [13] . Colonic tissue samples were homogenized using a potassium phosphate buffer containing 0.5% HTAB, subjected to three freezing/thawing cycles in liquid N2, and finally centrifuged to obtain a supernatant used to determine MPO levels with O-dianisidine, HTAB, and H 2 O 2 . MPO activity was expressed as enzyme activity units per mg of protein. Protein concentration was measured using the Bradford assay (Bio-Rad, Laboratories Inc., Hercules, CA, USA).
Determination of Pro-Inflammatory Cytokines in Colon and Mesenteric Lymph Nodes
On one hand, colonic tissue was subjected to mechanical homogenization and centrifugation in Tissue Protein Extraction Reagent (T-PER, Thermo Fisher Scientific, Waltham, Massachusetts, USA), supplemented with complete protease inhibitor cocktail (Roche). The levels of IL-1β, IL-6, IL-10, and TNF-α were determined by ELISA (Thermo Fisher Scientific, Waltham, MA, USA) and normalized to total protein, as measured by Bradford assay (Bio-Rad). On the other hand, mesenteric lymph nodes (MLN) from healthy mice (n = 3) were used to obtain a single cell suspension that was cultured in 24-well plates (1 × 10 6 cells/well) using RPMI-1640 medium, supplemented with 10% FBS and antibiotics, at 37 • C and 5% CO2. After 1 h, the cells were treated with PADF (12.5 µg/mL) for an additional hour and then stimulated with LPS (1 µg/mL) for 24 h. Finally, the supernatants were collected to determine IL-6 and MCP-1 levels by ELISA (Thermo Fisher Scientific).
Statistical Analysis
Results are expressed as the mean ± standard error of the mean (SEM) of at least two independent experiments. Data were analyzed using one-way analysis of variance (ANOVA), followed by Dunnett's post hoc test. Values of p < 0.05 were considered significant.
Results

Extraction of P. angulata and Preliminary Phytochemical Study of PADF
A total of 6.32 g of the dichloromethane fraction (PADF) were obtained from 234 g of dried calyces (2.70% yield) from P. angulata. The phytochemical characterization of F0-2 was performed by HPLC-DAD to generate a reliable chemical fingerprint to control the quality of future preparations and to predict bioactivity, as described in the Supplementary Information. However, the identity of the characteristic peaks of F0-2 remains unknown (Supplementary Figure S1 and Table S1), since there is a notorious lack of commercial standard compounds for Physalis genus [14] .
Moreover, considering that sucrose esters are described as the main anti-inflammatory metabolites from the calyces of Physalis [15] and several anti-inflammatories withanolides have been isolated from P. angulata, we quantified the total content of sucrose esters [16] and withanolides [17] (Supplementary Methods). The results revealed that calyces from P. angulata are an important source of sucrose esters whereas the withanolides were at a low level ( Supplementary Table S2 ).
PADF Modifies the Gene Expression Profile of Resting and LPS-Stimulated RAW 264.7 Macrophages Promoting an Anti-Inflammatory Polarization
To gain insight into the effects of PADF on macrophages differentiation, RAW 264.7 cells were treated with the test fraction (6.25 and 12.5 µg/mL) prior to polarization towards two contrasting activation states: inflammatory/LPS-activated [M(LPS)] and alternative/IL4-activated [M(IL4)]. As expected, inflammatory M(LPS) macrophages expressed higher mRNA levels of IL-1β, tumor necrosis factor (TNF)-α, IL-6, IL-12, cyclooxygenase (COX)-2, and inducible nitric oxide synthase (iNOS) (pro-inflammatory genes), as well as a strong reduction of arginase (ARG)1, IL-10, and mannose receptor C (MRC1) (anti-inflammatory genes) in comparison to the resting control (M0) ( Figure 1A,B ). In contrast, PADF significantly prevented the induction of pro-inflammatory genes, in a dose-dependent manner ( Figure 1A) . Additionally, the treatment with PADF significantly promoted the expression of anti-inflammatory genes (ARG1, IL-10, and MRC1) ( Figure 1B) .
Similarly, when evaluating these anti-inflammatory genes on M0 macrophages treated with PADF, a significant increase in the expression of ARG1, IL-10, TGF-β1, and MRC1 mRNA was also observed ( Figure 1C ); suggesting that PADF might be capable of inducing a macrophage polarization shift towards an anti-inflammatory profile. However, the well-known expression of ARG1 or MRC1 by alternatively activated macrophages M(IL4) was not boosted by test fraction; moreover, no effects on IL-10 were observed ( Figure 1D ).
Finally, the 24 h accumulation of nitrite (marker of iNOS activity), urea (marker of ARG1 activity), and IL-10 (immunosuppressive cytokine) were measured using the Griess reaction [18] , enzymatic detection or ELISA as detailed in Supplementary information. Results corroborated that PADF inhibited the production of nitrite by inflammatory M(LPS) macrophages, but did not increase the levels of urea in the case of alternative M(IL-4) macrophages (Supplementary Figure S3 ). However, when studying IL-10, the test fraction significantly inhibited its production by M(LPS) but had no effect in M(IL-4).
P. angulata Fraction (PADF) Ameliorates DSS-Induced Colitis
DSS intake produced a significant body weight decrease on the colitis-control group by the end of the last DSS cycle, while the administration of PADF at 5 and 10 mg/Kg/day managed to reverse this disease sign with a full recovery of their body weight (0.95% and 0.62% weight gain, respectively) without reaching statistical significance. Moreover, disease activity index (DAI) score also tended to be diminished by PADF treatment (Figure 2A ). A macroscopic evaluation was also performed in order to further assess the severity of the disease and the effect of the treatment, where colon length; a very common and important parameter in DSS-induced colitis, was measured. As can be seen in Figure 2B , both doses of PADF were able to significantly decrease the colon shortening when compared to the colitis-control group. The histologic analysis also showed that treatment with PADF (10 mg/Kg) produced a significant improvement in terms of edema, immune cell infiltration, and tissue structure integrity ( Figure 2C ) diminishing the histological score to 3.25 ± 0.33 in comparison to the colitis-control group (5.17 ± 0.33). Similarly, when evaluating these anti-inflammatory genes on M0 macrophages treated with PADF, a significant increase in the expression of ARG1, IL-10, TGF-β1, and MRC1 mRNA was also observed ( Figure 1C ); suggesting that PADF might be capable of inducing a macrophage polarization a very common and important parameter in DSS-induced colitis, was measured. As can be seen in Figure 2B , both doses of PADF were able to significantly decrease the colon shortening when compared to the colitis-control group. The histologic analysis also showed that treatment with PADF (10 mg/Kg) produced a significant improvement in terms of edema, immune cell infiltration, and tissue structure integrity ( Figure 2C ) diminishing the histological score to 3.25 ± 0.33 in comparison to the colitis-control group (5.17 ± 0.33). Besides histologic analysis, polymorphonuclear cell infiltration can be indirectly determined by measuring the levels of myeloperoxidase (MPO) in the tissue. As shown on Figure 3A , DSS intake significantly increased the MPO activity in the colon (91.60 ± 11.00 U/mg protein) compared to the control group (52.44 ± 9.38 U/mg protein). In accordance with the observations on the histologic slides, treatment with PADF (10 mg/Kg) was able to significantly reduce the MPO activity by 44% approximately. Similarly, the lower dose of PADF (5 mg/Kg) exerted a significant reduction of MPO activity, confirming indirectly that the test fraction reduced the infiltration of pro-inflammatory cells.
Furthermore, the administration of PADF was associated with a diminished expression of pro-inflammatory cytokines and over-expression of anti-inflammatory cytokines. Indeed, mice treated with PADF showed reduced levels of IL-1β and TNF-α, while levels of IL-10 were significantly increased. A non-significant decrease of IL-6 levels was also observed ( Figure 3A) .
Additionally, Figure 3B shows the effect of PADF on the production of IL-6 and MCP-1 by LPS-stimulated mesenteric lymph nodes (MLN) cells. The test fraction (12.5 µg/mL) did not affect the production of any of the soluble mediators on naïve cells. However, it significantly reduced the production of IL-6 and MCP-1 by LPS-stimulated MLN cells.
Besides histologic analysis, polymorphonuclear cell infiltration can be indirectly determined by measuring the levels of myeloperoxidase (MPO) in the tissue. As shown on Figure 3A , DSS intake significantly increased the MPO activity in the colon (91.60 ± 11.00 U/mg protein) compared to the control group (52.44 ± 9.38 U/mg protein). In accordance with the observations on the histologic slides, treatment with PADF (10 mg/Kg) was able to significantly reduce the MPO activity by 44% approximately. Similarly, the lower dose of PADF (5 mg/Kg) exerted a significant reduction of MPO activity, confirming indirectly that the test fraction reduced the infiltration of pro-inflammatory cells. Furthermore, the administration of PADF was associated with a diminished expression of proinflammatory cytokines and over-expression of anti-inflammatory cytokines. Indeed, mice treated with PADF showed reduced levels of IL-1β and TNF-α, while levels of IL-10 were significantly increased. A non-significant decrease of IL-6 levels was also observed ( Figure 3A) . 
Discussion
This study reveals the pharmacological potential of the dichloromethane fraction (PADF) of P. angulata calyces showing its capacity to ameliorate established DSS-colitis in mice. Our results suggest that PADF exerts its anti-inflammatory effect by inducing macrophage polarization towards a regulatory profile. In fact, PADF promotes a strong reduction of pro-inflammatory genes expression and a significant induction of anti-inflammatory markers, including IL-10, after stimulation with LPS or in resting macrophages. Moreover, a significant reduction of pro-inflammatory cytokines and the induction of IL-10 were observed in the colonic tissue of PADF-treated mice.
Physalis angulata is an annual herb that is distributed from North America (southeastern United States) to Central and South America (to Paraguay) and the Antilles [19] . In Colombia, this species grows from 0 to 1800 m above sea level and could be found throughout the country, where it constitutes one of the most common representatives of the Physalis genus. While the fruits are consumed by native indigenous communities, the aerial parts (including calyces) and fruits are commonly employed for its anti-inflammatory and anti-microbial properties [20] . So far, at least a dozen studies have demonstrated the ability of extracts, fractions, and compounds from P. angulata to inhibit inflammation and modulate the response of immune cells, including macrophages. To our knowledge, macrophages are the most commonly employed immune cells to study P. angulata derivatives, with all the reports employing LPS-stimulated macrophages [M(LPS)] and the quantification of pro-inflammatory mediators (such as NO, IL-6, and TNF-α) to demonstrate their anti-inflammatory properties. However, with the exception of Rivera et al. [7] , none of these reports focused on the calyces. Furthermore, no information is available regarding the impact of P. angulata on the expression of anti-inflammatory markers (i.e., IL-10 or TGF-β1) by M(LPS) macrophages or the modulation of resting macrophages (M0) or alternatively activated macrophages [M(IL-4)]. Our study is the first to demonstrate that treatment with PADF modulated macrophage polarization towards a non-inflammatory phenotype. Specifically, PADF shifted the inflammatory status of M(LPS) with a potent reduction of iNOS, COX-2, IL-1β, IL-6, and IL-12; that was accompanied by a significant increase of anti-inflammatory genes (ARG1, IL-10, MRC1, and TGF-β) which are poorly or not expressed by M0 or M(LPS) [21] . In all probability, this PADF-induced polarization does not promote the transition from the classically activated M(LPS) to the alternatively activated phenotype M(IL-4) since: (1) M0 treated with PADF not only expressed higher levels of alternative activation markers (i.e., ARG1 or MRC1), but also exhibited higher expression of anti-inflammatory genes (IL-10 and TGF-β); or (2) The treatment with PADF did not enhance the expression of alternative activation markers (i.e., ARG1 or MRC1) when stimulated with IL-4. In this case, results suggest that the phenotype promoted by PADF is similar to that induced by IL-10 [M(IL- 10) or M2c] which is more related to the suppression of immune responses and tissue remodeling through the expression of markers, such as IL-10, TGF-β, and MRC1 [22] .
As P. angulata is also employed in folk medicine to treat gastrointestinal discomfort [23] , and considering the crucial role of macrophages in the pathogenesis and resolution of inflammatory bowel disease, we continued our study with the assessment of PADF using a therapeutic setting of DSS-induced colitis in mice. Results demonstrated that administration of PADF (10 mg/Kg/day) to mice with DSS chronic colitis significantly reversed the colon shortening, reduced the histological damage, neutrophil infiltration (as showed by MPO activity assay), and the production of inflammatory cytokines (IL-1β and TNF-α). In addition, PADF induced the production of IL-10 in DSS-treated mice, a key immunoregulatory cytokine for the maintenance of intestinal homeostasis. In mice, macrophages are considered one of the most important sources of IL-10 to maintain and minimize mucosal immunopathology by promoting Foxp3 expression in regulatory T cells (Treg) and their function during colitis [24] . Hence, it is plausible that PADF significantly ameliorates DSS-colitis by means of macrophage transition towards an anti-inflammatory phenotype. This is reinforced by the decreased production of IL-6 and MCP-1 by activated MLN cells, mediators that also play a pivotal role in the migration and attraction of inflammatory macrophages to colonic tissue when damage is induced by DSS [25] . Further research is needed to undoubtedly demonstrate whether the effect of P. angulata is mediated by intestinal macrophages instead of other cell populations.
While this is not the first study describing the intestinal anti-inflammatory activity of P. angulata, since recently Almeida Junior et al. [26] demonstrated that a CO 2 standardized extract from the aerial parts of the plant-PACO2-effectively prevented the colonic damage induced by TNBS in rats; this is the first report of the bioactivity of calyces from P. angulata in a model of colitis. Moreover, our results revealed their potential to treat, instead of preventing, established intestinal inflammation.
Another important result of the present study was the confirmation of significant amounts of glycosides and withanolides; secondary metabolites that might be responsible for the bioactivity, as previously reported by Rivera et al. [7] . Up to date, all the studies related to the anti-inflammatory activity of P. angulata were directed to the assessment of withanolides such as physalins, aromaphysalins, physangulatins, and whitangulatins, labdane-type diterpenoids, such as physangulatosides, or phenol glycosides, namely physanguloside A. Here we found that sucrose esters tended to be the more abundant class of compounds in PADF; therefore, it is likely that the pharmacological effects of this fraction are related to their presence. In accordance, they have been described as the major anti-inflammatory compounds from calyces, fruits, or the sticky coat of several Physalis species [15, 27, 28] .
Overall, we have identified PADF as a regulator of macrophage activation and inflammation. Our data suggest a potential therapeutic role of P. angulata in inflammatory bowel disease.
